Γενικά > Κυκλοφορούντα φάρμακα και γενόσημα τους

Βγήκε στις ΗΠΑ βιο-ομοειδές (biosimilar) της Humalog.

(1/1)

Argirios Argiriou:
December 11, 2017

First Humalog Copycat (Admelog) Approved by FDA

Miriam E. Tucker


The US Food and Drug Administration (FDA) has approved Admelog (Sanofi-Adventis US), the first copycat version of short-acting insulin lispro (Humalog, Eli Lilly)  to treat individuals aged 3 years and older with type 1 diabetes and adults with type 2 diabetes.

The product is approved for use as an injection, via pump, or intravenously. It will be available both in vials and as a prefilled pen (Admelog SoloStar).

Δεν είναι ορατοί οι σύνδεσμοι (links). Εγγραφή ή Είσοδος

Πλοήγηση

[0] Λίστα μηνυμάτων